Patents by Inventor Jean Xu

Jean Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240350509
    Abstract: Salts and solid forms of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a stereoisomer thereof, are disclosed. Compositions comprising and methods of using the salts and solid forms are also disclosed.
    Type: Application
    Filed: July 3, 2024
    Publication date: October 24, 2024
    Inventors: Benjamin M. Cohen, John F. Traverse, Jean Xu, Ying Li
  • Publication number: 20240338397
    Abstract: Methods, apparatus, systems, and articles of manufacture to determine a number of denoising iterations of model output generation are disclosed. An example apparatus includes at least one programmable circuit to execute a model to generate a plurality of outputs based on a text-based prompt, each of the plurality of outputs generated using different numbers of denoising iterations; generate an ordered set of the plurality of outputs based on the number of denoising iterations; determine a plurality of similarities between neighboring outputs in the ordered set of the plurality of outputs; and select a number of denoising iterations based on the plurality of similarities.
    Type: Application
    Filed: June 17, 2024
    Publication date: October 10, 2024
    Inventors: Jean Xu Yu, Haim Shmuel Barad, Harsha Gupta
  • Patent number: 11890304
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: February 6, 2024
    Assignee: Janssen Biotech, Inc.
    Inventor: Jean Xu
  • Publication number: 20240002807
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.
    Type: Application
    Filed: June 16, 2023
    Publication date: January 4, 2024
    Applicant: Janssen Biotech, Inc.
    Inventors: Alireza Rezania, Jean Xu
  • Patent number: 11748621
    Abstract: An embodiment includes generating an input document that includes a plurality of text fields of attribute data. The embodiment also includes extracting a set of candidate features from the attribute data using a feature extraction module that evaluates the attribute data using first and second machine learning models, where the first machine learning model scores terms in the input document and the second machine learning model includes a deep learning model. The embodiment also includes calculating feature-selection values for respective features of the set of candidate features and generating tag information for a remote computing asset using a machine learning classifier that predicts the tag information based on the feature-selection values.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: September 5, 2023
    Assignee: Kyndryl, Inc.
    Inventors: Omar Odibat, Jean Xu Yu, Emrah Zarifoglu, Ilyas Mohamed Iyoob
  • Patent number: 11708562
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides an improved method for the formation of pancreatic endoderm, pancreatic hormone expressing cells and pancreatic hormone secreting cells. The present invention also provides methods to promote the differentiation of pluripotent stem cells without the use of a feeder cell layer.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: July 25, 2023
    Assignee: Janssen Biotech, Inc.
    Inventors: Alireza Rezania, Jean Xu
  • Publication number: 20230151332
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells into insulin producing cells. In particular, the present invention provides a method to produce cells expressing markers characteristic of the pancreatic endocrine lineage that co-express NKX6.1 and insulin and minimal amounts of glucagon.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 18, 2023
    Applicant: Janssen Biotech, Inc.
    Inventor: Jean Xu
  • Patent number: 11629153
    Abstract: The present invention provides solid forms of an MK2 inhibitor, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: April 18, 2023
    Assignee: Celgene CAR LLC
    Inventors: Jianxin Han, Lianfeng Huang, Uday Jain, Ying Li, John Malona, Kevin Molter, Chittari Pabba, Alexander L. Ruchelman, Jean Xu, Daozhong Zou
  • Publication number: 20230076569
    Abstract: An embodiment includes generating an input document that includes a plurality of text fields of attribute data. The embodiment also includes extracting a set of candidate features from the attribute data using a feature extraction module that evaluates the attribute data using first and second machine learning models, where the first machine learning model scores terms in the input document and the second machine learning model includes a deep learning model. The embodiment also includes calculating feature-selection values for respective features of the set of candidate features and generating tag information for a remote computing asset using a machine learning classifier that predicts the tag information based on the feature-selection values.
    Type: Application
    Filed: November 8, 2022
    Publication date: March 9, 2023
    Inventors: Omar Odibat, Jean Xu Yu, Emrah Zarifoglu, llyas Mohamed lyoob
  • Publication number: 20230061503
    Abstract: The present disclosure relates to methods of early identification and detection of neurotoxicity associated with the administration of chimeric antigen receptor (CAR) T cell therapy and mitigation strategies to reduce the occurrence and/or severity of treatment associated neurotoxicity.
    Type: Application
    Filed: May 10, 2022
    Publication date: March 2, 2023
    Inventors: Muhammad S. AKRAM, Kevin C. De Braganca, Jenna Goldberg, Carolyn Chang Jackson, Erin C. Lee, Nikoletta Lendvai, Maria Marquez de Mondelo, Yunsi Olyslager, Jun Qiu, Enrique Zudaire Ubani, Jean Xu
  • Patent number: 11526754
    Abstract: An embodiment includes generating an input document that includes a plurality of text fields of attribute data. The embodiment also includes extracting a set of candidate features from the attribute data using a feature extraction module that evaluates the attribute data using first and second machine learning models, where the first machine learning model scores terms in the input document and the second machine learning model includes a deep learning model. The embodiment also includes calculating feature-selection values for respective features of the set of candidate features and generating tag information for a remote computing asset using a machine learning classifier that predicts the tag information based on the feature-selection values.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: December 13, 2022
    Assignee: Kyndryl, Inc.
    Inventors: Omar Odibat, Jean Xu Yu, Emrah Zarifoglu, Ilyas Mohamed Iyoob
  • Publication number: 20220296653
    Abstract: The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.
    Type: Application
    Filed: June 2, 2022
    Publication date: September 22, 2022
    Applicant: Janssen Biotech, Inc.
    Inventor: Jean Xu
  • Patent number: 11369642
    Abstract: The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: June 28, 2022
    Assignee: Janssen Biotech, Inc.
    Inventor: Jean Xu
  • Publication number: 20220125797
    Abstract: Salts and solid forms of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a stereoisomer thereof, are disclosed. Compositions comprising and methods of using the salts and solid forms are also disclosed.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 28, 2022
    Inventors: Benjamin M. Cohen, John F. Traverse, Jean Xu, Ying Li
  • Patent number: 11303530
    Abstract: An embodiment includes calculating an efficacy value of a context assigned to an asset, the efficacy value being based at least in part on a percentage of assets assigned to the context. The embodiment also includes calculating, responsive to the calculated efficacy value being within a predetermined range, a normalized relevance value of a first tag associated with the asset. The embodiment also includes generating relative relevance value for the first tag and a reason code associated with a basis for the relative relevance value of the first tag based at least in part on the normalized relevance value of the first tag. The embodiment also includes initiating, responsive to generating the relative relevance value and the reason code for the first tag, a database command on a training dataset stored in the database that includes the first tag.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: April 12, 2022
    Assignee: KYNDRYL, INC.
    Inventors: Jean Xu Yu, Keri Wheatley, Angelo Danducci, II
  • Patent number: 11241439
    Abstract: Salts and solid forms of 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione, or a stereoisomer thereof, are disclosed. Compositions comprising and methods of using the salts and solid forms are also disclosed.
    Type: Grant
    Filed: February 25, 2020
    Date of Patent: February 8, 2022
    Assignee: Celgene Corporation
    Inventors: Benjamin M. Cohen, John F. Traverse, Jean Xu, Ying Li
  • Publication number: 20210297322
    Abstract: An embodiment includes calculating an efficacy value of a context assigned to an asset, the efficacy value being based at least in part on a percentage of assets assigned to the context. The embodiment also includes calculating, responsive to the calculated efficacy value being within a predetermined range, a normalized relevance value of a first tag associated with the asset. The embodiment also includes generating relative relevance value for the first tag and a reason code associated with a basis for the relative relevance value of the first tag based at least in part on the normalized relevance value of the first tag. The embodiment also includes initiating, responsive to generating the relative relevance value and the reason code for the first tag, a database command on a training dataset stored in the database that includes the first tag.
    Type: Application
    Filed: March 18, 2020
    Publication date: September 23, 2021
    Applicant: International Business Machines Corporation
    Inventors: Jean Xu Yu, Keri Wheatley, Angelo Danducci, II
  • Publication number: 20210248457
    Abstract: An embodiment includes generating an input document that includes a plurality of text fields of attribute data. The embodiment also includes extracting a set of candidate features from the attribute data using a feature extraction module that evaluates the attribute data using first and second machine learning models, where the first machine learning model scores terms in the input document and the second machine learning model includes a deep learning model. The embodiment also includes calculating feature-selection values for respective features of the set of candidate features and generating tag information for a remote computing asset using a machine learning classifier that predicts the tag information based on the feature-selection values.
    Type: Application
    Filed: February 7, 2020
    Publication date: August 12, 2021
    Applicant: International Business Machines Corporation
    Inventors: Omar Odibat, Jean Xu Yu, Emrah Zarifoglu, Ilyas Mohamed Iyoob
  • Publication number: 20210198276
    Abstract: The present invention provides solid forms of an MK2 inhibitor, compositions thereof, and methods of using the same.
    Type: Application
    Filed: December 29, 2020
    Publication date: July 1, 2021
    Inventors: Jianxin Han, Lianfeng Huang, Uday Jain, Ying Li, John Malona, Kevin Molter, Chittari Pabba, Alexander L. Ruchelman, Jean Xu, Daozhong Zou
  • Patent number: 10882867
    Abstract: The present invention provides solid forms of an MK2 inhibitor, compositions thereof, and methods of using the same.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: January 5, 2021
    Assignee: Celgene CAR LLC
    Inventors: Jianxin Han, Lianfeng Huang, Uday Jain, Ying Li, John Malona, Kevin Molter, Chittari Pabba, Alexander L. Ruchelman, Jean Xu, Daozhong Zou